Health

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care

From advancements in male birth control to the science of supplements, Scientific American highlights some of the most fascinating health and medicine stories of 2025

A look back at 2025’s biggest science stories—from federal upheaval and public health setbacks to climate policy reversals and groundbreaking discoveries in space.

The U.S. reportedly plans to overhaul the country’s childhood vaccine schedule. The move could set public health back decades, experts say

Health officials on Thursday announced a slew of measures that seek to restrict access to gender-affirming health care for young transgender people in the U.S.

A novel influenza variant called subclade K appears to be driving an uptick in cases and hospitalizations throughout the U.S. and other countries

President Donald Trump is expected to sign a defense bill this week that orders an investigation into whether the U.S. military bioengineered Lyme disease

Whether space, health, technology or environment, here are the issues in science that the editors of Scientific American are focusing on for 2026

Popular supplements with billions of “good” microbes really help only a few illnesses, research shows

These three disorders could really be “CKM syndrome,” which can be treated with drugs like Ozempic

Pregnant people who receive a COVID vaccine are 60 percent less likely to experience severe disease and around 30 percent less likely to give birth prematurely, according to new research

A recent analysis showed the rate of uninsured children in the U.S. grew from 2022 to 2024. Experts say this could lead to more pediatric cancer deaths